Pharmaceutical solids are able to exist in several forms: polymorphic crystalline and amorphous arrangements. They present differences in their physico-chemical properties, for instance, melting point, density, morphology, solubility and color. These characteristics may have an impact on the stability (physical and chemical), bioavailability and bioequivalence1; e.g. amorphous substances are unstable than crystalline substances. Differences in degrees of drug crystallization affect chemical and physical stability, rather than crystalline polymorphism of the substance.
